US › Healthcare

OraSure Technologies Inc (OSUR)

US · Healthcare · Medical Instruments & Supplies

$4.17+0.24%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$27.9M
Revenue YoY
-6.7%
Net profit
$-22.4M
Profit YoY
-39.5%
EPS
$-0.24
EPS estimate
$-0.17
Net margin
-80.1%

EPS came in at -0.24 against a street estimate of -0.17 — a miss of 41.2%.

Key statistics

Market cap
$278.8M
Forward P/E
40.0
P/B
0.89
Book value
$4.51
EPS (TTM)
$-1.05
52-week high
$4.58
52-week low
$2.08
50-day MA
$4.11
200-day MA
$3.12
Beta
1.00

Analyst view

Analysts rate OraSure Technologies Inc a buy (1 buy, 3 hold, 0 sell out of 4) with an average price target of $4.00.

Shareholding

Insiders
6.38%
Institutions
86.66%

Largest institutional holders

FundStake
BlackRock Inc9.46%
Private Management Group Inc7.88%
Neuberger Berman Group LLC6.34%
Altai Capital Management, L.P.5.25%
Vanguard Capital Management, LLC4.40%
Dimensional Fund Advisors, Inc.4.10%
Systematic Financial Management LP3.60%
Renaissance Technologies Corp3.03%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for OraSure Technologies Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.